Mannheimia haemolytica infections
Index
- Pictures
- Identity
- Pathogen/s
- Overview
- Host Animals
- Hosts/Species Affected
- Systems Affected
- Distribution
- Distribution Table
- Pathology
- Diagnosis
- List of Symptoms/Signs
- Disease Course
- Epidemiology
- Impact: Economic
- Impact: Environmental
- Impact: Social
- Zoonoses and Food Safety
- Disease Treatment
- Prevention and Control
- References
- Links to Websites
- Contributors
- Distribution Maps
Don't need the entire report?
Generate a print friendly version containing only the sections you need.
Generate reportIdentity
Top of pagePreferred Scientific Name
- Mannheimia haemolytica infections
International Common Names
- English: bovine pneumonic mannheimiosis; bovine respiratory disease; calf pneumonia; enzootic calf pneumonia; ewe mastitis; mannheimia haemolytica pneumonia, shipping fever, pasteurellosis; mannheimia haemolytica-like organism associated with diarrhea in swine; Mannheimia mastitis; mannheimia mastitis in goats; mannheimia mastitis in sheep; Mannheimia pleuritis; Mannheimia pneumonia; mannheimia pneumonia, shipping fever, pasteurellosis; mannheimia, pasteurella mastitis in cattle; mannheimia, pasteurella pneumonia of sheep and goats; mannheimia, pasteurella pneumonia, septicemia, of sheep and goats; mannheimiosis; mastitis; mastitis in ewes due to miscellaneous bacteria; necrotizing pleuropneumonia in pigs; otitis media, externa, interna, middle and inner ear infections; Pasteurella haemolytica infections; Pasteurella mastitis; Pasteurella pleuritis; pasteurella, mannheimia, pneumonia, pleuritis, in swine; pasteurellosis; pasteurellosis in cattle; pasteurellosis of sheep and goats; pasteurellosis of swine; pneumonic pasteurellosis; septicemic pasteurellosis; septicemic pasteurellosis of cattle; septicemic pasteurellosis of sheep; septicemic pasteurellosis of swine; shipping fever; shipping fever pneumonia; stockyard pneumonia; summer mastitis; summer mastitis in cattle; systemic pasteurellosis; transit fever
- French: mannheimiose
Local Common Names
- Italy: pasteurellosi
English acronym
- BRD
Overview
Top of pageMannheimia haemolytica (from Greek haima - blood, lyt – adverb form of verb lyo - dissolve, and adjectival suffix – ikos latinized in – ica) is a Gram-negative bacterium which produces a weak haemolytic phenotype on sheep blood agar plates. This microorganism corresponds to Pasteurella haemolytica biogroup 1 which in 1999 was renamed as Mannheimia, in tribute to Walter Mannheim, a German microbiologist who studied the taxonomy of the family Pasteurellaceae (Angen et al., 1999).
M. haemolytica is an important cause of bacterial respiratory mortality in cattle, sheep and goats; moreover, it is responsible for mastitis in ewes and camels, and rarely for abortion in cattle. It also causes a rare respiratory disease in pigs associated with Actinobacillus pleuropneumoniae, and it has been isolated from some wild and domesticated birds (Odugbo et al., 2004; Blackall et al., 2002; Christensen et al., 2003; Dewani et al., 2002; Frank, 1998; Martino, 2000; Oladele et al., 1999).
Healthy animals carry M. haemolytica as a nasal and nasopharyngeal commensal without developing clinical signs. However, when cattle (particularly younger animals) are stressed (for example in transportation from pastured herds to feedlots), and/or become infected with respiratory viruses, M. haemolytica replicates and is inhaled into the lower respiratory tract where it causes great damage. In addition, other opportunistic bacteria such as Pasteurella multocida, Histophilus somni, or Trueperella pyogenes (formerly Arcanobacterium pyogenes) can also take advantage of the damage done to the respiratory tissue. The interaction between the various pathogens can cause respiratory disease, which as a result is often referred to as bovine respiratory disease complex.
In particular, M. haemolytica is the principal microorganism responsible for bovine pneumonic pasteurellosis (older name) or mannheimiosis, also known as shipping fever. This respiratory disease is an economically significant disease in cattle, accounting for about 30% of total cattle deaths in the world; it is associated with an annual economic loss of over US $1 billion in North America alone (Miles, 2009; Frank, 1998).
There are several pathogenicity factors associated with M. haemolytica: fimbriae, capsule, lipopolysaccharide, leukotoxin, etc. It causes several clinical signs in domestic and wild animals: fever, cough, nasal discharge, weight loss, etc. (Alley, 2002; Kanwar et al., 1998; Alhendi, 2000; Ali and Youssef, 2003; Frank, 1998; Catry et al., 2002).
Antimicrobials such as tilmicosin, tildipirosin, danofloxacin, oxytetracycline, amoxicillin and clavulanic acid are used against the bacterium (Aslan et al., 2002; Christodoulopoulos et al., 2002; Frank et al., 2002; Hurd, 1999; Amrine et al., 2014; Lubbers and Turnidge, 2015) and vaccination to reduce the incidence of respiratory disease is widespread (Auad et al., 2001; Choe et al., 2000; Cusack, 2004; Hay et al., 2016).
Although M. haemolytica is not normally an important zoonotic agent, it can cause serious disease in human infants and immunocompromised adults; it has been demonstrated in septicaemia of infants and in adults with heart disease (Punpanich and Srijuntongsiri, 2012; Takeda et al., 2003).
There is a separate datasheet on the sheep disease atypical non-progressive proliferative pneumonia, to which M. haemolytica can be a contributory cause.
Host Animals
Top of pageAnimal name | Context | Life stage | System |
---|---|---|---|
Anas (ducks) | |||
Bos bison (American bison) | |||
Bos grunniens (yaks) | Domesticated host | ||
Bos indicus (zebu) | Domesticated host | ||
Bos mutus (yaks, wild) | |||
Bos taurus (cattle) | Domesticated host | ||
Bubalus bubalis (Asian water buffalo) | Domesticated host | Cattle and Buffaloes|All Stages | |
Camelus dromedarius (dromedary camel) | Domesticated host | Other|Adult Female; Other|Adult Male | |
Capra hircus (goats) | Domesticated host | Sheep and Goats|All Stages | |
Equus asinus (donkeys) | Domesticated host | ||
Equus caballus (horses) | Domesticated host | ||
Gallus | |||
Gallus gallus domesticus (chickens) | Domesticated host | ||
Lama glama (llamas) | Domesticated host | ||
Lama pacos (alpacas) | Domesticated host | ||
Meleagris | Domesticated host | ||
Meleagris gallopavo (turkey) | Domesticated host | ||
Mus musculus (house mouse) | Experimental settings | ||
Oryctolagus cuniculus (rabbits) | Experimental settings | ||
Ovis aries (sheep) | Domesticated host | Sheep and Goats|All Stages | |
Ovis canadensis | Wild host | Sheep and Goats|All Stages | |
Panthera onca | Wild host | ||
Struthio camelus (ostrich) | Domesticated host | Poultry|All Stages | |
Sus scrofa (pigs) | Domesticated host |
Hosts/Species Affected
Top of pageIn cattle, Mannheimia haemolytica is responsible for a severe respiratory syndrome, which is often a consequence of several stressors such as transportation (‘shipping fever’ or ‘shipping fever pneumonia’), the gathering of animals coming from different geographical areas, adverse climatic conditions (excessive cold, heat, rain, or wind) or pronounced food changes (Euzeby, 1999; Taylor, 1998; Martin et al., 1998; Martino, 2000; Frank, 1998; Taylor et al., 2010a). Respiratory infections due to viruses or Mycoplasma are also predisposing factors, because they may enhance the localized multiplication of M. haemolytica by altering the mechanisms of defence of the lower respiratory tract, including the lungs (Rice et al., 2007; Singh et al., 2011b).
In sheep and goats there are several factors that predispose to respiratory diseases, usually in adult animals: climatic changes, overcrowding, lack of adequate shelter, transport, viral infections, mycoplasmosis, bordetellosis, pasteurellosis due to Pasteurella multocida, anaplasmosis, trypanosomiasis (in Africa), and nutrient deficiencies (especially of copper). Infections due to M. haemolytica are generally observed all year round, but can be more often observed at the end of spring and at the beginning of summer (this form is also known as ‘summer pneumonia’), or during colder seasons in some African countries (Euzeby, 1999; Sisay and Zerihun, 2003; Berry, 1998; Dewani et al., 2002; Dziva and Mohan, 2000). Sheep mastitis due to M. haemolytica and Staphylococcus aureus causes substantial economic and disease losses to the sheep industry (Gelasakis et al., 2015).
In free ranging North American Bighorn sheep (Ovis canadensis), M. haemolytica (and also Bibersteinia trehalosi) cause severe pneumonia in all age groups (Besser et al., 2013). These bacteria have been largely responsible for the large decline in the Bighorn sheep population. Dall Sheep (Ovis dalli) have been infected in the laboratory (Foreyt et al., 1996).
In American bison (Bos bison), M. haemolytica is associated with disease in domestic livestock, but it is a potential pathogen for the bison themselves, particularly in animals that become stressed by management practices commonly used with cattle, such as herding, crowding and shipping (Taylor et al., 1996).
M. haemolytica has been isolated from ostriches with respiratory infection in Egypt (Ali and Youssef, 2003) and in some wild and domesticated birds (parrots, falcons, quails, peacocks, ostriches, pigeons, turkeys, guineafowl and ducks) in Nigeria. This last identification of M. haemolytica was only an occasional isolation during an epidemiological survey, but the bacterium has been reported in adult turkeys (Birbir et al., 1995; Christensen et al., 2003; Oladele et al., 1999; Ibrahim et al., 2000).
In camels, M. haemolytica is responsible for mastitis and respiratory diseases (Al Rawashdeh et al., 2000; Alhendi, 2000; Bekele and Molla, 2001).
M. haemolytica was reported to induce pericarditis in a jaguar (Kim et al., 2001), although this was in a mixed infection with heartworm.
Isolation of M. haemolytica has been reported from sea turtles found on beaches in Italy (Zizzo et al., 2003).
Experimental pasteurellosis has been induced in rabbits (Heng et al., 1996), and it is possible to reproduce the pulmonary infection in laboratory mice, particularly in SCID-beige or SCID-bo (reconstituted with bovine spleen cells) mice (Thorn et al., 2000) (Gatto et al., 2006). Bronchopneumonia was induced, with lesions similar to those that develop in the lungs of cattle infected with M. haemolytica; however, the lesions appear to be a result primarily of lipopolysaccharide and not leukotoxin -- SCID-bo mice had similar lesions whether wild or LKT deficient mutant M. haemolytica was used for the challenge.
Systems Affected
Top of pageblood and circulatory system diseases of pigs
blood and circulatory system diseases of small ruminants
digestive diseases of pigs
mammary gland diseases of large ruminants
mammary gland diseases of pigs
mammary gland diseases of small ruminants
multisystemic diseases of large ruminants
multisystemic diseases of pigs
multisystemic diseases of poultry
multisystemic diseases of small ruminants
reproductive diseases of poultry
respiratory diseases of large ruminants
respiratory diseases of pigs
respiratory diseases of poultry
respiratory diseases of small ruminants
Distribution
Top of pageThe geographical distribution of Mannheimia haemolytica is worldwide, although specific references for every country were not available for the Distribution table. The microorganism is reported most frequently in Asia and in countries where sheep or goat breeding is widespread, such as in Africa and North America. In Europe, pasteurellosis or mannheimiosis is also widespread and involves many countries where sheep and cattle are present, such as the Netherlands, Denmark, Germany, Italy and France (Topolko and Benic, 1997; Tefera and Smola, 2002a,b; Angen et al., 2002; Thomas et al., 2001; Ewers et al., 2004; Fels-Klerx et al., 2002; Catana et al., 1997; Lyakh and Androsik, 1996; Harwood, 2004).
Distribution Table
Top of pageThe distribution in this summary table is based on all the information available. When several references are cited, they may give conflicting information on the status. Further details may be available for individual references in the Distribution Table Details section which can be selected by going to Generate Report.
Last updated: 10 Jan 2020Continent/Country/Region | Distribution | Last Reported | Origin | First Reported | Invasive | Reference | Notes |
---|---|---|---|---|---|---|---|
Africa |
|||||||
Benin | Present | ||||||
Cameroon | Present | ||||||
Egypt | Present | ||||||
Ethiopia | Present | ||||||
Nigeria | Present | ||||||
South Africa | Present | ||||||
Sudan | Present | ||||||
Zimbabwe | Present | ||||||
Asia |
|||||||
India | Present | ||||||
-Himachal Pradesh | Present | ||||||
-Rajasthan | Present | ||||||
Iran | Present | ||||||
Iraq | Present | ||||||
Israel | Present | ||||||
Japan | Present | ||||||
Jordan | Present | ||||||
Malaysia | Present | ||||||
Pakistan | Present | Native | |||||
Saudi Arabia | Present | ||||||
South Korea | Present | ||||||
Sri Lanka | Present | ||||||
Syria | Present | ||||||
Turkey | Present | ||||||
Vietnam | Present | ||||||
Europe |
|||||||
Belgium | Present | ||||||
Croatia | Present | ||||||
Czechia | Present | ||||||
Denmark | Present | ||||||
France | Present | ||||||
Germany | Present | ||||||
Greece | Present | ||||||
Hungary | Present | ||||||
Italy | Present | ||||||
Netherlands | Present | ||||||
Norway | Present | ||||||
Romania | Present | ||||||
Russia | Present | ||||||
Spain | Present | ||||||
Sweden | Present | ||||||
United Kingdom | Present | ||||||
North America |
|||||||
Canada | Present | ||||||
-Alberta | Present | ||||||
-Manitoba | Present | ||||||
-Ontario | Present | ||||||
Mexico | Present | ||||||
United States | Present | Native | |||||
-California | Present | ||||||
-Colorado | Present | ||||||
-Idaho | Present | ||||||
-Iowa | Present | ||||||
-Kansas | Present | ||||||
-Michigan | Present | ||||||
-Minnesota | Present | ||||||
-Montana | Present | ||||||
-Nebraska | Present | ||||||
-Nevada | Present | ||||||
-New Mexico | Present | ||||||
-North Dakota | Present | ||||||
-Oklahoma | Present | ||||||
-Oregon | Present | ||||||
-South Dakota | Present | ||||||
-Tennessee | Present | ||||||
-Texas | Present | ||||||
-Wyoming | Present | ||||||
Oceania |
|||||||
Australia | Present | ||||||
-New South Wales | Present | ||||||
-Queensland | Present | ||||||
New Zealand | Present | ||||||
South America |
|||||||
Argentina | Present | ||||||
Brazil | Present, Localized | Present based on regional distribution. | |||||
-Minas Gerais | Present | ||||||
-Paraiba | Present | ||||||
-Rio Grande do Sul | Present | ||||||
Peru | Present |
Pathology
Top of pageIn bovine mannheimiosis, the hallmark histopathological feature of the disease is alveoli filled with fibrin interspersed with neutrophils and macrophages. Larger airways are often spared inflammatory changes unless there are complicating bacteria or viruses. Interlobular septa are expanded due to fibrin-rich edema with lymphatic thrombi and a mild leukocyte infiltrate. In addition, fibrin is present on the pleural surface, and the mesothelium is denuded or hypertrophied. Lymphocytes, neutrophils and macrophages may infiltrate the subpleura. Within a few days, thrombosis of vessels with coagulation necrosis of entire or nearly entire lobules is noted (Caswell and Williams, 2007).
Septicemic bovine mannheimiosis is rare and usually occurs terminally in cattle that have severe pneumonia (Mahu et al., 2015; Odendaal and Henton, 1995). M. haemolytica septicemia has also been associated with dairy cattle with naturally occurring coliform mastitis (Wenz et al., 2001). In the case of sheep with septicemia, the older literature can be unclear in that many of the cases of Pasteurella haemolytica septicemia were likely what is now Bibersteinia trehalosi; however, M. haemolytica can cause septicemia in lambs that are <3 months old (Caswell and Williams, 2007; Mackie et al., 1995). M. haemolytica has also been demonstrated in septicemia of human infants or in people with heart disease (Punpanich and Srijuntongsiri, 2012; Takeda et al., 2003).
In the pathology of domestic and Bighorn sheep and goat lungs, lesions consist of large areas of cranioventral haemorrhagic to suppurative to fibrinosuppurative bronchopneumonia that may have fibrin on the pleural surface (Caswell and Williams, 2007). Septicaemia of lambs causes sero-haemorrhagic effusions, and haemorrhages in the serosal membranes, epicardium and lungs, particularly in the peripheric lobes. The abomasal space and some intestinal tracts show a catarrhal-haemorrhagic inflammation. There is also obvious serofibrinous pleuritis and pericarditis (Caswell and Williams, 2007).
In camels, the major postmortem lesions are hydrothorax, adhesion of the lung to the thorax, emphysema, hydropericardium and fibrinous pericarditis (Seddek, 2002).
Diagnosis
Top of pageClinical Diagnosis
In calves, it is possible to observe general depression with fever (41°C), anorexia, substantial weight loss, cough, respiratory distress and nasal discharge; death may follow 24-48 h after onset (Frank, 1998; Munish Batra et al., 2002; Martino, 2000; Odendaal and Henton, 1995; Timsit et al., 2016).
In sheep and goats, initially moderate respiratory signs (cough, nasal discharge) are observed, and then worsen to pneumonia with fever (40.6–42.6°C). Animals may die in a few hours or show dyspnoea (Odendaal and Henton, 1995, Sasani et al., 2002, Ozbey and Muz, 2004, Zaitoun, 2001).
In ovine mastitis it is possible to observe a severe, usually unilateral, necrotizing inflammation of the mammary gland with other generic systemic signs (fever, anorexia, depression, inappetence). At the beginning, milk is clear and watery; it then becomes yellowish, viscous and clotted (Dewani et al., 2002, Fthenakis, 1994).
In camels, the major clinical signs observed are fever of 40-41.5°C, depression, cough, loss of appetite and a watery nasal discharge that becomes purulent at a later stage. Finally, the camel becomes recumbent and extends its neck along the ground (El Jakee, 1998; Bekele, 1999).
Laboratory Diagnosis
Tentative diagnosis is by clinical observation, but this should be confirmed by pathogen isolation. Clinical sampling methods include using nasal swabs (although M. haemolytica can be commensal in the nasal cavity), tracheo-bronchial lavage or broncho-alveolar lavage. There is reasonable agreement regarding isolation of M. haemolytica or other respiratory pathogens between culture results using nasal swabs, transtracheal wash, guarded nasopharyngeal swab, or bronchoalveolar lavage fluid (Capik et al., 2017; Doyle et al., 2017). At necropsy, sampling the pulmonary parenchyma, blood, spleen, liver and bronchial lymph nodes is recommended. The bacteriological examination of milk allows differential diagnosis of mastitis due to M. haemolytica from mastitis with another aetiological agent.
The Cary-Blair medium, modified by the addition of horse blood serum, is the most effective medium for the transport of M. haemolytica strains (Tefera and Smola, 2002a).
Samples can be plated on various bacteriological media such as Columbia agar, Brain Heart Infusion agar, Trypticase soy agar, or blood agar with 5-10 % of bovine or sheep blood. The incubation is made in aerobic atmosphere or with an atmosphere enriched with CO2. After 24 h of incubation, the colonies are round with a diameter of 1-2 mm. The presence of haemolytic activity is not necessarily diagnostic as it is variable and depends on the type of erythrocyte used in the medium (bovine blood is generally better), nonhaemolytic strains of M. haemolytica have also been found associated with disease (Mahu et al., 2015).
Identification has usually been based on morphological and biochemical characteristics such as nitrate reduction, glucose fermentation, oxidase reaction, etc. However, molecular techniques and MALDI-TOF assays are rapidly replacing conventional bacteriologic techniques (Kumar et al., 2015; Puchalski et al., 2016). Polymerase chain reaction (PCR) can be used for identification of M. haemolytica from samples (Dutta et al., 2001, Katsuda et al., 2003).
It is possible to use the API System 20NE® (BioMerièux, France), a miniaturized biochemical system, for identification of M. haemolytica. The ENTERORapid 24 kit (BioMerièux, France) is the fastest kit for the identification of the bacterial strains (within 4 to 8 h), with a correct identification rate at the species level (Tefera and Smola, 2002b).
Serotyping is done in a reference laboratory, often using indirect hemagglutination or direct agglutination assays (Younan and Fodor, 1995; Christensen et al., 2003). Strain variations among M. haemolytica isolates can be separated using pulse-field gel electrophoresis (PFGE), ribotyping, random amplified polymorphic DNA (RAPD), and genome sequencing analysis for differentiation of the bacterial strains (Klima et al., 2014; Klima et al., 2016).
Differential Diagnosis
Differential diagnosis from Histophilus somni and Pasteurella multocida infections is required in bovine bronchopneumonia (Fulton et al., 2009; Panciera and Confer, 2010). In fact, M. haemolytica is frequently mixed with P. multocida or other bacteria in shipping fever or in respiratory disease of dairy calves. Differential diagnosis is based on the pathological features of the respiratory tract, besides the morphological aspects on agar plate and the biochemical profile. In general, besides a fibrinous bronchopneumonia, H. somni may induce fibrinous synovitis and/or multifocal myocarditis or myocardial infarction, whereas P. multocida pneumonia is more commonly a suppurative bronchopneumonia with little fibrinous pleuritis (Panciera and Confer, 2010).
List of Symptoms/Signs
Top of pageSign | Life Stages | Type |
---|---|---|
Acoustic Signs / Deafness | Sign | |
Acoustic Signs / Purulent, mucoid discharge, excess wax, foul odour, ears | Sign | |
Acoustic Signs / Rubbing ears, scratching | Sign | |
Cardiovascular Signs / Prolonged capillary refill time | Sign | |
Cardiovascular Signs / Tachycardia, rapid pulse, high heart rate | Sign | |
Cardiovascular Signs / Weak pulse, small pulse | Sign | |
Digestive Signs / Anorexia, loss or decreased appetite, not nursing, off feed | Sign | |
Digestive Signs / Bloody stools, faeces, haematochezia | Sign | |
Digestive Signs / Diarrhoea | Sign | |
Digestive Signs / Difficulty in prehending or chewing food | Sign | |
Digestive Signs / Dysphagia, difficulty swallowing | Sign | |
Digestive Signs / Excessive salivation, frothing at the mouth, ptyalism | Sign | |
Digestive Signs / Vomiting or regurgitation, emesis | Sign | |
General Signs / Ataxia, incoordination, staggering, falling | Sign | |
General Signs / Cyanosis, blue skin or membranes | Sign | |
General Signs / Dehydration | Sign | |
General Signs / Dysmetria, hypermetria, hypometria | Sign | |
General Signs / Exercise intolerance, tires easily | Sign | |
General Signs / Fever, pyrexia, hyperthermia | Sign | |
General Signs / Forelimb lameness, stiffness, limping fore leg | Sign | |
General Signs / Generalized lameness or stiffness, limping | Sign | |
General Signs / Generalized weakness, paresis, paralysis | Sign | |
General Signs / Haemorrhage of any body part or clotting failure, bleeding | Sign | |
General Signs / Head, face, ears, jaw weakness, droop, paresis, paralysis | Sign | |
General Signs / Head, face, ears, jaw, nose, nasal, swelling, mass | Sign | |
General Signs / Hindlimb lameness, stiffness, limping hind leg | Sign | |
General Signs / Hypothermia, low temperature | Sign | |
General Signs / Inability to stand, downer, prostration | Sign | |
General Signs / Lack of growth or weight gain, retarded, stunted growth | Sign | |
General Signs / Lymphadenopathy, swelling, mass or enlarged lymph nodes | Sign | |
General Signs / Mammary gland swelling, mass, hypertrophy udder, gynecomastia | Sign | |
General Signs / Opisthotonus | Sign | |
General Signs / Petechiae or ecchymoses, bruises, ecchymosis | Sign | |
General Signs / Reluctant to move, refusal to move | Sign | |
General Signs / Stiffness or extended neck | Sign | |
General Signs / Sudden death, found dead | Sign | |
General Signs / Torticollis, twisted neck | Sign | |
General Signs / Underweight, poor condition, thin, emaciated, unthriftiness, ill thrift | Sign | |
General Signs / Weight loss | Sign | |
Nervous Signs / Circling | Sign | |
Nervous Signs / Dullness, depression, lethargy, depressed, lethargic, listless | Sign | |
Nervous Signs / Head shaking, headshaking | Sign | |
Nervous Signs / Head tilt | Sign | |
Nervous Signs / Tremor | Sign | |
Ophthalmology Signs / Chemosis, conjunctival, scleral edema, swelling | Sign | |
Ophthalmology Signs / Conjunctival, scleral, injection, abnormal vasculature | Sign | |
Ophthalmology Signs / Conjunctival, scleral, redness | Sign | |
Ophthalmology Signs / Corneal edema, opacity | Sign | |
Ophthalmology Signs / Corneal neovascularization, pannus | Sign | |
Ophthalmology Signs / Corneal ulcer, erosion | Sign | |
Ophthalmology Signs / Decreased or absent menace response but not blind | Sign | |
Ophthalmology Signs / Decreased tearing, lacrimation | Sign | |
Ophthalmology Signs / Hypopyon, lipid, or fibrin, flare, of anterior chamber | Sign | |
Ophthalmology Signs / Lacrimation, tearing, serous ocular discharge, watery eyes | Sign | |
Ophthalmology Signs / Miosis, meiosis, constricted pupil | Sign | |
Ophthalmology Signs / Nystagmus | Sign | |
Ophthalmology Signs / Photophobia | Sign | |
Ophthalmology Signs / Ptosis, lid droop | Sign | |
Ophthalmology Signs / Purulent discharge from eye | Sign | |
Ophthalmology Signs / Strabismus | Sign | |
Pain / Discomfort Signs / Ocular pain, eye | Sign | |
Pain / Discomfort Signs / Pain mammary gland, udder | Sign | |
Pain / Discomfort Signs / Pain, head, face, jaw, ears | Sign | |
Pain / Discomfort Signs / Skin pain | Sign | |
Reproductive Signs / Abortion or weak newborns, stillbirth | Cattle and Buffaloes|Cow; Cattle and Buffaloes|Heifer | Sign |
Reproductive Signs / Agalactia, decreased, absent milk production | Sign | |
Reproductive Signs / Bloody milk, red, pink, brown milk | Sign | |
Reproductive Signs / Cold mammary gland, cool udder | Sign | |
Reproductive Signs / Edema of mammary gland, udder | Sign | |
Reproductive Signs / Firm mammary gland, hard udder | Sign | |
Reproductive Signs / Mastitis, abnormal milk | Sign | |
Reproductive Signs / Slough of mammary gland, udder | Sign | |
Reproductive Signs / Warm mammary gland, hot, heat, udder | Sign | |
Respiratory Signs / Abnormal breath odor, foul odor mouth | Sign | |
Respiratory Signs / Abnormal breathing sounds of the upper airway, airflow obstruction, stertor, snoring | Sign | |
Respiratory Signs / Abnormal lung or pleural sounds, rales, crackles, wheezes, friction rubs | Sign | |
Respiratory Signs / Coughing, coughs | Sign | |
Respiratory Signs / Decreased, muffled, lung sounds, absent respiratory sounds | Sign | |
Respiratory Signs / Dull areas on percussion of chest, thorax | Sign | |
Respiratory Signs / Dyspnea, difficult, open mouth breathing, grunt, gasping | Sign | |
Respiratory Signs / Epistaxis, nosebleed, nasal haemorrhage, bleeding | Sign | |
Respiratory Signs / Increased respiratory rate, polypnea, tachypnea, hyperpnea | Sign | |
Respiratory Signs / Mucoid nasal discharge, serous, watery | Sign | |
Respiratory Signs / Purulent nasal discharge | Sign | |
Skin / Integumentary Signs / Cold skin, cool ears, extremities | Sign | |
Skin / Integumentary Signs / Rough hair coat, dull, standing on end | Sign | |
Skin / Integumentary Signs / Skin erythema, inflammation, redness | Sign | |
Skin / Integumentary Signs / Skin necrosis, sloughing, gangrene | Sign | |
Skin / Integumentary Signs / Subcutaneous crepitation, skin emphysema | Sign | |
Skin / Integumentary Signs / Warm skin, hot, heat | Sign |
Disease Course
Top of pageThe pathogenesis of infections by Mannheimia haemolytica is not well understood. After colonization of the upper respiratory tract, the microorganism colonizes the lower respiratory tract and finally enters the alveolar spaces (Singh et al., 2011b). At these sites, there is a strong influx of neutrophils, which is associated with alveolar epithelial damage and necrosis, which results in increased vascular permeability, leading to alveolar flooding and pulmonary dysfunction. M. haemolytica lipopolysaccharide is probably involved in the initial increased vascular permeability and activation of macrophages (Singh et al., 2011a; Singh et al., 2012; Whiteley et al., 1990).
Neutrophils cause lung damage by release of elastase, myeloperoxidase and reactive oxygen intermediates, which cause structural degradation of lung tissue (Malazdrewich et al., 2004). Lung damage due to release of neutrophil hydrolytic enzymes is enhanced by the membrane effects of leukotoxin on neutrophils (Czuprynski, 2009; Lo, 2001). In addition, neutrophils can secrete cytokines, which can amplify and sustain the inflammatory response in the lung, resulting in lung pathology associated with disease. The inflammatory cytokines tumor necrosis factor α (TNF-α), IL-1β and IL-8 play a pivotal role in the initiation of the interactions between cytokines, leukocytes, vascular endothelium, cellular adhesion molecules and soluble chemotactic factors (Singh et al., 2011b). Studies indicate that bovine IL-8 is a chemoattractant for neutrophils and plays a key role in the genesis of lung injury associated with bovine pneumonic mannheimiosis (Malazdrewich et al., 2001; Caswell et al., 2001).
Pneumonic mannheimiosis is characterized in feedlot cattle by acute fibrinopurulent pleuropneumonia. Morbidity is due to substantial weight loss, obstruction of bronchioles due to fibrinous exudate, accumulation of macrophages and fibrin in the alveoli, and subsequent thrombosis and lymphatic vessel distention. The disease can rapidly progress to fatality (Apley, 2006) .
In ovine mastitis, the nursing lamb is suspected of both introducing the agent and providing the mechanical trauma needed for the development of clinical disease, which is characterized by severe, usually unilateral, necrotizing inflammation of the mammary gland (‘blue bag’) (Dewani et al., 2002, Scott and Jones, 1998). M. haemolytica adheres to mammary epithelial cells, which is considered critical for colonization. A study in vitro (Vilela et al., 2004) has demonstrated that adherence and internalization mechanisms may be present in the onset of mastitis caused by M. haemolytica. These mechanisms may be an important feature of the development of mastitis, allowing bacteria to survive and persist in the mammary gland.
Septicaemia of sheep due to M. haemolytica and the closely related Bibersteinia trehalosi takes two forms. M. haemolytica most often occurs in lambs less than 3 months old, involving severe pleuritis, synovitis, and pericarditis. B. trehalosi most often occurs in lambs of 5-12 months of age and is acute or peracute; outbreaks of disease often coincide with a change in diet or other stress. It is postulated that microorganisms already present in the tonsils multiply and invade the adjacent tissues of the alimentary tract. Microorganisms enter the bloodstream as emboli and lodge in the capillary beds of the lung, liver and spleen. Rapid multiplication of M. haemolytica in these tissues leads to death (Lopez and Martinson, 2017).
In adult camels, M. haemolytica has been isolated from pneumonic lungs and from cases of chronic, suppurative mastitis (Woubit et al., 2001; Alhendi, 2000; El Jakee, 1998). In addition, M. haemolytica has been isolated from laryngeal abscesses in alpaca crias (Dwan et al., 2008).
Epidemiology
Top of pageMannheimia haemolytica is a commensal of the nasopharynx of cattle and sheep, but it can act as a primary pathogen in septicaemia of lambs or in bronchopneumonia of calves and cattle (Taylor et al., 2010a, b).
Many ruminant species carry M. haemolytica as a commensal in the nasopharynx and tonsils (cattle, sheep, goat, buffaloes, etc.), but it causes disease in only a few species. Sheep and goats are most often affected, followed by cattle and buffaloes, in which it is often possible to observe diseases associated with stress of transportation (shipping fever), sometimes associated with Pasteurella multocida, Mycoplasma bovis, and Histophilus somni infections and viral agents (such as parainfluenza-3 virus, bovine respiratory syncytial virus, bovine viral diarrhea virus, or bovine herpesvirus-1) (Taylor et al., 2010a). In other species, such as camelids, wild and domesticated birds, etc., the bacterium is isolated less frequently and is generally associated with viral and mycoplasmal infections, or mixed infections with other bacteria (Kanwar et al., 1998; Mackie et al., 1995; Martin et al., 1998; Khan and Khan, 1997; Martrenchar et al., 1995; O’Connor et al., 2001; Oladele et al., 1999; Ward et al., 1999). Some further information on predisposing factors in different species is provided in the 'Hosts/species affected' section.
Calves, lambs, and kids develop nasal colonization at a young age via direct transmission from the dam via nasal secretions or droplets, by transmission from one young animal to another, or through fomites. M. haemolytica and P. multocida have been isolated from the nasal passages of some dairy calves as early as 24-36 hours after birth (Step et al., 2005). Epidemiological studies in several states of the USA have attempted to identify risk factors for morbidity and mortality both at the individual calf and herd levels. Approximately 40-80% of all diseases of cattle in various countries involve the respiratory system, and bovine respiratory disease complex is the most important problem; it involves three clinical syndromes, of which shipping fever and pneumonic mannheimiosis are due to M. haemolytica (Hay et al., 2014; Hay et al., 2016; Murray et al., 2016; Murray et al., 2017; Sivula et al., 1996).
In Africa, especially in Ethiopia, bronchopneumonia, mainly attributed to M. haemolytica, causes both morbidity (18.6%) and mortality (10.6%) in sheep and goats. In this environment the highest percentage of bacterial isolation was recorded from September to November (Sisay and Zerihun, 2003).
In experiments, the survival of M. haemolytica was 1 h on a wooden plank and 24 h in straw maintained at 20°C. Nevertheless, relative humidity and cold weather increase its survival, which can reach 48 h at 4°C, 3 days in milk or in water at 20 °C, 7 days in water at 4°C and 8 days in milk at 4°C (Euzeby, 1999).
Impact: Economic
Top of pageIn the USA, pneumonia caused by M. haemolytica is the main cause of economic losses in the breeding of calves. The same condition is also observed in Europe (Fels-Klerx et al., 2002). In addition, M. haemolytica is the second commonest agent causing mastitis in goats in Europe and is one of the main aetiological agents of this disease in USA. Gelasakis et al. (2015) report that sheep mastitis due to M. haemolytica and Staphylococcus aureus causes substantial economic and disease losses to the sheep industry
Financial losses that result from calf pneumonia occur due to death, treatment cost and decreased lifetime productivity (and possibly a lower grade of meat in cattle treated multiple times for the disease). Michigan dairy producers estimated that respiratory disease in calves cost them US $14.71 per calf/year (Kaneene and Hurd, 1990) while producers in California estimated that calf respiratory disease cost them US $9 per calf/year (Sischo et al., 1990). The economic loss is over US $1 billion in North American beef and dairy cattle (Miles, 2009) (Griffin, 1997).
A study in two dairies in Mexico (Pijoan and Chavez, 2003) evaluated direct and indirect costs of losses due to pneumonia. Direct costs included fatalities, discards and treatment. Indirect costs included vaccination and preventive treatment. The range varied from US $52.78 per calf to US $24.72 per calf.
Impact: Environmental
Top of pageIn free ranging North American Bighorn sheep (Ovis canadensis), M. haemolytica (and also Bibersteinia trehalosi) cause severe pneumonia in all age groups (Besser et al., 2013). These bacteria have been largely responsible for the large decline in the Bighorn sheep population.
Impact: Social
Top of pageBecause respiratory disease is the major cause of economic losses in the beef cattle industry and M. haemolytica is such a major cause of bovine pneumonia, antibiotics are used in large amounts to control the pneumonia (Rice et al., 2007). This practice has led to concern that high antibiotic use in meat and dairy cattle can lead to antimicrobial resistance in human pathogens (Oliver et al., 2011).
Although M. haemolytica is not normally an important zoonotic agent, it can cause serious disease in human infants and immunocompromised adults; it has been demonstrated in septicaemia of infants and in adults with heart disease (Punpanich and Srijuntongsiri, 2012; Takeda et al., 2003).
Zoonoses and Food Safety
Top of pageMannheimia haemolytica is not normally an important zoonotic agent, but it can cause serious disease in infants and immunocompromised adults; it has been demonstrated in septicaemia of infants and in adults with heart disease (Punpanich and Srijuntongsiri, 2012; Takeda et al., 2003).
Heat treatment of milk (pasteurization or ultra-high temperature treatment) allows elimination of M. haemolytica and assures milk safety. However, in countries where milk is consumed untreated and the microorganism is widely spread, risk of infection could be high.
Mass medication of livestock used in treatment and prevention of bovine respiratory disease increases the risk of unwanted drug residues in meat and milk intended for human consumption.
Disease Treatment
Top of pageAt present, treatment of bovine pneumonic mannheimiosis is based almost exclusively on systemic antibiotic therapy. In fact, there are many antibiotics that are used for treatment, often both in calves and in lambs. Examples are oxytetracycline, danofloxacin, enrofloxacin, marbofloxacin, tilmicosin, tildipirosin, amoxicillin plus clavulanic acid, talaromycin and florfenicol, with a dosage ranging from 6 mg/kg to 20 mg/kg (Apley, 2006; Aslan et al., 2002; Christodoulopoulos et al., 2002; Cusack, 2004; Frank et al., 2002; Hurd, 1999; Rowan et al., 2004; Sarasola et al., 2002; Schwan, 1998; Thomas et al., 2001; Traeder and Grothues, 2004).
Furthermore, metaphylactic administration of long-acting antibiotics (such as oxytetracycline, tilmicosin, enrofloxacin, or tildipirosin) to calves on arrival at the feedlot has become a common preventive measure. This procedure reduces morbidity and mortality during the early feeding period in calves (Malazdrewich et al., 2004).
The bovine strains are more resistant than ovine strains to several antibiotics: ampicillin, streptomycin, neomycin, gentamicin, tetracycline, chloramphenicol, etc. (Euzeby, 1999, Singer et al., 1998).
The resistance to ampicillin is due to plasmids that code for a β-lactamase named ROB-1, the resistance to chloramphenicol is due to the synthesis of an acetyltransferase III coded by a plasmid that can also act on florfenicol. A chromosomal gene encodes for resistance to sulfonamides (Euzeby, 1999).
Current evidence indicates that widespread use of antibiotics may have contributed to the emergence of multiple antibiotic-resistant strains of M. haemolytica (Malazdrewich et al., 2004; Euzeby, 1999). Mass medication of cattle with antibiotics also promotes the transfer of antibiotic resistance genes from animal pathogens to human bacterial pathogens. Other approaches to bovine mannheimiosis, such as improved vaccines and immunostimulants, are therefore being researched as alternatives to antibiotic mass medication.
Prevention and Control
Top of pageVaccination with formalized bacterins has been practised for almost 60 years with a questionable efficacy. Killed bacterins induce agglutinating antibodies in vaccinated cattle but with little or no antitoxic response and some evidence that bacterin-vaccinated cattle are more susceptible to disease (Rice et al., 2007). Better protection has been demonstrated after immunization with live organisms or component vaccines composed of soluble and surface antigens, including outer membrane proteins and leukotoxin (Shewen and Wilkie, 1988). Vaccination using these vaccines stimulates both antitoxic and opsonizing antibodies (Auad et al., 2001; Choe et al., 2000; Frank et al., 2002; Kerkhofs et al., 2004; Marchart et al., 2003; Stevens et al., 1997). Experimentally, commercial M. haemolytica vaccines can be enhanced by augmentation with recombinant surface or secreted proteins (Confer et al., 2003; Confer et al., 2006; Shewen et al., 2003).
Larson and Step (2012) carried out a systematic review of the effectiveness of vaccines against bacterial respiratory pathogens in feedlot cattle. They concluded that the published body of evidence does not provide a consistent estimate of the direction and magnitude of effectiveness of vaccination against Mannheimia haemolytica, Pasteurella multocida, or Histophilus somni.
Some of the many vaccines that have been developed for preventing M. haemolytica infections are listed below. Note that veterinary advice should always be taken before using vaccines or treatments mentioned in this Compendium.
LeukoTox (AAH)
Leukotox is a bacterin-toxoid that uses a combination of oil, water and other potentiators of the immune system. The product was designed to be used with re-vaccination 2 to 3 weeks apart so that the animals would have the maximum effect from the bacterin. It can be used for M. haemolytica and P. multocida; LeukoTox 1 (AHH) is a vaccine for M. haemolytica only.
Once PMH and Once PMH IN (Merck)
Must be used for vaccinating healthy cattle against respiratory disease caused by M. haemolytica and Pasteurella multocida. Aadminister 2 ml i.m., with annual revaccination. A single 2-ml dose is recommended.
One Shot (Zoetis)
This is a bacterin-toxoid for vaccination of healthy cattle as an aid to the prevention of infection caused by M. haemolytica type A1. Inject 2 ml s.c. least 14 days before weaning, shipping or exposure to stress or infectious conditions. A booster is recommended whenever subsequent stress or exposure is likely.
A 21-day slaughter withdrawal is required.
Anaphylactic reactions may occur.
Pyramid 4 plus Presponse SQ (Boehringer Ingelheim)
Pyramid 4 is a modified-live vaccine for bovine herpes virus 1 (IBRV), bovine viral diarrhoea virus (BVDV), bovine parainfluenza virus 3 (PI3) and bovine respiratory syncytial virus (BRSV), and Presponse SQ is a preparation of M. haemolytica toxoid for vaccination of healthy dairy or beef cattle of 6 months of age or older. Inject 2 ml i.m. or s.c.; do not use in pregnant cows or calves nursed by pregnant cows.
21-day slaughter withdrawal period.
Anaphylactic reactions may occur.
Triangle 9+PH-K (Boehringer Ingelheim)
This is used for the vaccination of healthy cattle against IBR, BVDV, PI3, BRSV and infections caused by M. haemolytica and the 5 most common strains of Leptospira. Inject 5 ml i.m., and repeat in 14-28 days. Revaccinate calves at weaning, and then revaccinate annually.
21-day slaughter withdrawal.
Anaphylactic reactions may occur.
Presponse HM and Presponse SQ (Boehringer Ingelheim)
These vaccines provide cattle with protection against M. haemolytica and Pasteurella multocida.
Pulmo-guard PH-1 (AgriLabs)
This is a M. haemolytica bacterin toxoid containing leukotoxoids and antigens from chemically inactivated cultures of multiple isolates of the two bacteria in a triple adjuvant.
Inject 2 ml s.c. (ready to use, single dose) in front of shoulder and midway in the neck away from the suprascapular lymph node. A booster dose is recommended 21 days before subsequent stress. Annual revaccination is recommended.
Do not vaccinate within 60 days before slaughter.
Anaphylactic reactions may occur.
Pulmo-guard PH-M (AgriLabs)
This is a M. haemolytica and P. multocida bacterin-toxoid and contains leukotoxoids and antigens from chemically inactivated cultures of multiple isolates of the two bacteria in a double adjuvant.
Ready to use; single dose; inject 2 ml s.c. or i.m. in the middle of the neck. Repeat in 14 to 28 days. Annual revaccination is recommended.
Do not vaccinate within 60 days before slaughter.
Anaphylactic reactions may occur.
References
Top of pageAli AR, Youssef AE, 2003. Bacteriological studies and biochemical parameters of respiratory infection in ostriches. Veterinary Medical Journal Giza, 51(2):189-203
Alley MR, 2002. Pneumonia in sheep in New Zealand: an overview. New Zealand Veterinary Journal, 50(3 Supplement):99-101; 39 ref
Al-Sultan II, 1995. Prevalence of Pasteurella haemolytica serotypes causing pneumonic pasteurellosis in Iraqi sheep. Iraqi Journal of Veterinary Sciences, 8(1):163-166; 15 ref
Al-Tarazi YHM, 2002. The efficacy of an experimental Pasteurella hemolytica vaccine as measured by seroconversion in Awassi lambs in Jordan. 1st International Conference on Sheep and Goat Diseases and Productivity, Irbid, Jordan, 23 25 October 1999. Small Ruminant Research, 45(2):201-208
Berry E, 1998. Update on summer mastitis. Proceedings of the British Mastitis Conference 1998, 46-53; 17 ref
Caswell JL, Williams KJ, 2007. Respiratory System. In: Maxie G, ed. Pathology of Domestic Animals. Edinburgh, UK: Saunders, 523-653
Catana N, Necsulescu M, Lazau A, Herman V, Ramneantu M, Ciorba D, 1997. The prevalence of Pasteurella infections in calves with respiratory diseases (Prevalenta infectiei cu pasteurella la viteii cu afectiuni respiratorii). Al 22-lea simpozion, Cluj-Napoca, 1996. Actualitati în patologia animalelor domestice: lucrari stiintifice, 288-290; 11 ref
Choe ChangYong, Lee MyeongSik, Na SeungHwan, Jung YoungHun, Yoon SoonSeek, Choe SangYong, Na KieJun, 2000. Vaccination and mass medication for preventing shipping fever in Korean native cattle. Korean Journal of Veterinary Clinical Medicine, 17(1):52-56; 19 ref
Christensen H, Bisgaard M, Bojesen AM, Mutters R, Olsen JE, 2003. Genetic relationships among avian isolates classified as Pasteurella haemolytica, ‘Actinobacillus salpingitidis’ or Pasteurella anatis with proposal of Gallibacterium anatis gen. nov., comb. nov. and description of additional genomospecies within Gallibacterium gen. nov.. International Journal of Systematic and Evolutionary Microbiology, 53(1):275-287
Cusack PMV, 2004. Effect of mass medication with antibiotics at feedlot entry on the health and growth rate of cattle destined for the Australian domestic market. Australian Veterinary Journal, 82(3):154-156
Dutta TK, Singh VP, Kumar AA, 2001. Rapid and specific diagnosis of haemorrhagic septicaemia by using PCR assay. Indian Journal of Animal Health, 40(2):101-107
Dziva F, Mohan K, 2000. Pasteurellosis and Pasteurellae in Zimbabwe: an update. Zimbabwe Veterinary Journal, 31(1):1-10; 39 ref
El Jakee J, 1998. Microbiological studies on mammary glands of one humped she-camels in Egypt. Journal of Camel Practice and Research, 5(2):243-246
Euzeby JP, 1999. Mannheimia. Dictionnaire de Bactériologie Vétérinaire. On-line: http://www.bacterio.cict.fr/bacdico/mm/mannheimia.html
Ewers C, Lubke Becker A, Wieler LH, 2004. Mannheimia haemolytica and the pathogenesis of pneumonic pasteurellosis (Mannheimia haemolytica und die Pathogenese der Enzootischen Bronchopneumonie). Berliner und Munchener Tierarztliche Wochenschrift, 117(3-4):97-115
Fels-Klerx HJ van der, Martin SW, Nielen M, Huirne RBM, 2002. Effects on productivity and risk factors of Bovine Respiratory Disease in dairy heifers, a review for the Netherlands. Netherlands Journal of Agricultural Science, 50(1):27-45
Frank GH, 1998. Pasteurella haemolytica and pneumonic pasteurellosis in transported cattle. Proceedings One Hundred and Second Annual Meeting of the United States Animal Health Association, Minneapolis, Minnesota, USA, 3-9 October, 1998., 348-355; 41 ref
Griffin D, 1997. Economic impact associated with respiratory disease in beef cattle. Veterinary Clinics of North America, Food Animal Practice, 13(3):367-377; 23 ref
Harwood, D., 2004. Diseases of dairy goats. In Practice, 26(5), 248-259.
Hurd DR, 1999. Marbocyl [marbofloxacin] - an advanced fluoroquinolone for the treatment of bovine respiratory disease (BRD). Irish Veterinary Journal, 52(2):95, 97
Ismail TM, Hatem ME, 1998. Prevalence of subclinical mastitis in a dairy cattle herd in the Eastern region of Saudi Arabia. In: Shehab MM, El Tahlawy MR, Mahmoud MR, eds. Eighth Scientific Congress, Faculty of Veterinary Medicine, Assiut University, 15 17 November, 1998. Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt, 646-653
Kang HeeJung, Kim IkChun, Kim JinHoe, Son WonGeun, Lee DuSik, Kang HJ, Kim IC, Kim JH, Son WG, Lee DS, 2001. Identification and antimicrobial susceptibility of microorganisms isolated from bovine mastitic milk. Korean Journal of Veterinary Research, 41(4):511-521
Katsuda K, Kohmoto M, Kawashima K, Tsunemitsu H, Tsuboi T, Eguchi M, 2003. Molecular typing of Mannheimia (Pasteurella) haemolytica serotype A1 isolates from cattle in Japan. Epidemiology and Infection, 131(2):939-946
Kerkhofs P, Tignon M, Petry H, Mawhinney I, Sustronck B, 2004. Responses to bovine respiratory syncytial virus (BRSV) following use of an inactivated BRSV PI3 Mannheimia haemolytica vaccine and a modified live BRSV BVDV vaccine. Veterinary Journal, 167(2):208-210
Kim JeongRae, Kim BangHyun, Yoo HanSang, Lee DeogYong, Kim KiGeun, Jean KyungSun, Hwang WooSuk, Lee ByungChun, Kim DaeYong, Kim JR, Kim BH, Yoo HS, Lee DY, Kim KG, Jean KS, Hwang WS, Lee BC, Kim DY, 2001. Concurrent infection with heartworm and Pasteurella haemolytica induced pericarditis in a jaguar (Panthera onca onca). Journal of Veterinary Clinics, 18(1):85-87
Le Van Tao, Pham Son Ho, 1998. Experimental reproduction of pasteurellosis in goats with Pasteurella isolated from goats in North Vietnam. Khoa Hoc Ky Thuat Thu Y, 5(2):46-52
Lopez A, Martinson SA, 2017. Respiratory System, Mediastinum, and Pleurae. In: Zachary JF, ed. Pathologic Basis of Veterinary Disease, 6th ed. St. Louis, Missouri, USA: Elsevier, 471-560
Lyakh YuG, Androsik NN, 1996. Prevalence of pasteurellosis in cattle and pigs in Belarus. Veterinarnaya nauka - proizvodstvu, 136-140; 4 ref
Malazdrewich C, Thumbikat P, Maheswaran SK, 2004. Protective effect of dexamethasone in experimental bovine pneumonic mannheimiosis. Microbial Pathogenesis, 36:227-236
Marchart J, Dropmann G, Lechleitner S, Schlapp T, Wanner G, Szostak MP, Lubitz W, 2003. Pasteurella multocida and Pasteurella haemolytica ghosts:new vaccine candidates. Vaccine, 21(25-26):3988-3997
Martino PA, 2000. Microbiological studies on bovine respiratory disease, a review (Indagini microbiologiche in corso di BRD). Obiettivi e Documenti Veterinari, 21(10):29-32; 21 ref
Odugbo MO, Okpara JO, Abechi SA, Kumbish TI, 2004. An outbreak of pneumonic pasteurellosis in sheep due to Mannheimia (Pasteurella) haemolytica serotype 7. Veterinary Journal, 167(2):214-215
Oladele SB, Raji MT, Raji MA, 1999. Prevalence of bacterial and fungal microflora isolated from some wild and domesticated birds in Zaria, Nigeria. Bulletin of Animal Health and Production in Africa, 47(3):127-132
Ozbey G, Muz A, 2004. Isolation of aerobic bacterial agents from the lungs of sheep and goats with pneumonia and detection of Pasteurella multocida and Mannheimia haemolytica by polymerase chain reaction. Turk Veterinerlik ve Hayvancilik Dergisi, 28(1):209-216
Pijoan Aguade P, Chavez Duron JA, 2003. Cost of pneumonia in dairy calves lodged under two housing systems. Veterinaria Mexico, 34(4):333-342
Purdy CW, Straus DC, Harp JA, Mock R, 2001. Microbial pathogen survival study in a high plains feedyard playa. Texas Journal of Science, 53 (3):247-266
Rowan TG, Sarasola P, Sunderland SJ, Giles CJ, Smith DG, 2004. Efficacy of danofloxacin in the treatment of respiratory disease in European cattle. Veterinary Record, 154(19):585-589
Sasani F, Atyabi N, Dehaghi MR, 2002. Pneumonic pasteurellosis (Fibrinous bronchopneumonia) in lamb due to pasteurella hemolytica (Biotype T). Journal of the Faculty of Veterinary Medicine, University of Tehran, 57(3):73-74
Shewen PE, Wilkie BN, 1988. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Canadian Journal of Veterinary Research 52, 30-36
Sisay T, Zerihun A, 2003. Diversity of Mannheimia haemolytica and Pasteurella trehalosi serotypes from apparently healthy sheep and abattoir specimens in the highlands of Wollo, North East Ethiopia. Veterinary Research Communications, 27(1):3-14
Tefera G, Smola J, 2002. Modification of Cary Blair transport medium for Pasteurella multocida and Mannheimia haemolytica. Acta Veterinaria Brno, 71(2):229-233
Traeder W, Grothues M, 2004. Pharmacological characteristics and efficacy of Tulathromycin, the first representative of the Triamilide antibiotics. Tierarztliche Umschau, 59(2):102-113
Vilela CL, Fitzpatrick J, Morgan K, 2004. In vitro adherence and invasion of ovine mammary epithelium by Mannheimia (Pasteurella) haemolytica. Veterinary Journal, 167(2):211-213
Distribution References
Al-Tarazi YHM, 2002. The efficacy of an experimental Pasteurella hemolytica vaccine as measured by seroconversion in Awassi lambs in Jordan. In: Small Ruminant Research [1st International Conference on Sheep and Goat Diseases and Productivity, Irbid, Jordan, 23 25 October 1999], 45 (2) 201-208.
CABI, Undated. CABI Compendium: Status inferred from regional distribution. Wallingford, UK: CABI
CABI, Undated a. CABI Compendium: Status as determined by CABI editor. Wallingford, UK: CABI
Catana N, Necsulescu M, Lazau A, Herman V, Ramneantu M, Ciorba D, 1997. The prevalence of Pasteurella infections in calves with respiratory diseases. (Prevalenta infectiei cu pasteurella la viteii cu afectiuni respiratorii). In: Al 22-lea simpozion, Cluj-Napoca, 1996. Actualitati în patologia animalelor domestice: lucrari stiintifice, 288-290.
Ismail TM, Hatem ME, 1998. Prevalence of subclinical mastitis in a dairy cattle herd in the Eastern region of Saudi Arabia. In: Eighth Scientific Congress, Faculty of Veterinary Medicine, Assiut University, 15 17 November, 1998, [ed. by Shehab MM, El Tahlawy MR, Mahmoud MR]. Assiut, Egypt: Faculty of Veterinary Medicine, Assiut University. 646-653.
Lyakh YuG, Androsik NN, 1996. Prevalence of pasteurellosis in cattle and pigs in Belarus. In: Veterinarnaya nauka - proizvodstvu, 136-140.
Links to Websites
Top of pageWebsite | URL | Comment |
---|---|---|
Pneumonic Pasteurellosis – Iowa State University | https://vetmed.iastate.edu/vdpam/FSVD/swine/index-diseases/pneumonic-pasteurellosis |
Contributors
Top of page30/04/2017 Revised for Invasive Species Compendium by:
Anthonw W. Confer, Oklahoma State University, Stillwater, Oklahoma, USA
30/11/2004 Original text by:
Piera Martino, University of Milan, Italy.
Distribution Maps
Top of pageSelect a dataset
Map Legends
-
CABI Summary Records
Map Filters
Unsupported Web Browser:
One or more of the features that are needed to show you the maps functionality are not available in the web browser that you are using.
Please consider upgrading your browser to the latest version or installing a new browser.
More information about modern web browsers can be found at http://browsehappy.com/